Profil bibliographique

Gary R. Lichtenstein

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

53Publications signalées

439Citations signalées

1Affiliations récentes

Les institutions déclarées

University of Pennsylvania

Les domaines associés

Inflammatory Bowel DiseaseMicroscopic ColitisEosinophilic EsophagitisHelicobacter pylori-related gastroenterology studiesLiver Diseases and Immunity

Les publications récentes

2025 conference-abstract OpenAlex

S1685 Maintenance of Endoscopic and Histologic Efficacy With Guselkumab for Ulcerative Colitis at Week 92 of the QUASAR Long-Term Extension Study

Tadakazu Hisamatsu, Julián Panés, Fernando Magro, Gary R. Lichtenstein et autres

0 citations The American Journal of Gastroenterology

Accès ouvert 2025 article OpenAlex

Long-term efficacy and safety of upadacitinib in patients with moderately to severely active ulcerative colitis: an interim analysis of the phase 3 U-ACTIVATE long-term extension study

Remo Panaccione, Séverine Vermeire, Silvio Danese, Peter Higgins et autres

ca, be, it, us, jp, de (code pays fourni par la source)

24 citations The Lancet. Gastroenterology & hepatology

2025 conference-abstract OpenAlex

Su1841: EFFICACY AND SAFETY OF UPADACITINIB AFTER 4 YEARS OF TREATMENT IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: INTERIM LONG-TERM DATA FROM THE PHASE 3 OPEN-LABEL EXTENSION STUDY (U-ACTIVATE)

Remo Panaccione, Gary R. Lichtenstein, Jean Frédéric Colombel, Hiroshi Nakase et autres

0 citations Gastroenterology

2025 conference-abstract OpenAlex

Su1856: EFFICACY AND SAFETY OF GUSELKUMAB FOR ULCERATIVE COLITIS THROUGH WEEK 92 OF THE QUASAR LONG-TERM EXTENSION STUDY

Gary R. Lichtenstein, Jessica R. Allegretti, David T. Rubin, Brian G. Feagan et autres

2 citations Gastroenterology

2024 conference-abstract OpenAlex

S1342 Impact of Baseline Disease Duration on Ozanimod Efficacy in Patients With Moderately to Severely Active Ulcerative Colitis: A Post Hoc Analysis of the Phase 3 True North Study

Gary R. Lichtenstein, Geert D’Haens, Alissa Walsh, Sarah C. Glover et autres

us, nl, gb (code pays fourni par la source)

0 citations The American Journal of Gastroenterology

2024 book OpenAlex

Ulcerative Colitis

Gary R. Lichtenstein

0 citations

2024 book-chapter OpenAlex

Oral and Parenteral Corticosteroids in Ulcerative Colitis

Leonard Baidoo, Gary R. Lichtenstein

0 citations

Accès ouvert 2024 article OpenAlex

759 THE EFFICACY AND SAFETY OF GUSELKUMAB AS MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 QUASAR MAINTENANCE STUDY

David T. Rubin, Jessica R. Allegretti, Julián Panés, Nicole Shipitofsky et autres

14 citations Gastroenterology

2024 conference-abstract OpenAlex

Su1860 GUSELKUMAB IMPROVES HEALTH-RELATED QUALITY OF LIFE AS MEASURED BY PROMIS-29 IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: PHASE 3 QUASAR INDUCTION STUDY

Julián Panés, Axel Dignaß, Gary R. Lichtenstein, Kuan‐Hsiang Gary Huang et autres

0 citations Gastroenterology

2024 conference-abstract OpenAlex

Su1862 GUSELKUMAB IMPROVES SYMPTOMS OF FATIGUE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: PHASE 3 QUASAR INDUCTION STUDY RESULTS AT WEEK 12

Axel Dignaß, Julián Panés, David T. Rubin, Kuan‐Hsiang Gary Huang et autres

0 citations Gastroenterology

2024 conference-abstract OpenAlex

Su1809 ASSESSMENT OF STEROID USE IN PATIENTS WITH ACTIVE ULCERATIVE COLITIS WHO INITIATED A NEW JANUS KINASE INHIBITOR OR TUMOR NECROSIS FACTOR INHIBITOR USING DATA FROM A UNITED STATES CLAIMS DATABASE

Marla C. Dubinsky, Milena Gianfrancesco, Geneviève Gauthier, Lara Fallon et autres

0 citations Gastroenterology

Accès ouvert 2023 article OpenAlex

913b THE EFFICACY AND SAFETY OF GUSELKUMAB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 QUASAR INDUCTION STUDY

Jessica R. Allegretti, Laurent Peyrin‐Biroulet, Brian G. Feagan, Brian Bressler et autres

9 citations Gastroenterology

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.